These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3606609)

  • 1. An improved method for the detection of malignancy by proton NMR spectroscopy of plasma.
    Otvos JD; Coffer MC; Chen SM; Wehrli S
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1397-403. PubMed ID: 3606609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
    Dowd TL; Kaplan BA; Gupta RK; Aisen P
    Magn Reson Med; 1987 Oct; 5(4):395-7. PubMed ID: 3683172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton nuclear magnetic resonance methyl and methylene linewidths from plasma decrease during postprandial lipemia.
    Verdery RB; Benham DF; McLennan I; Busby MJ; Wehrle JP; Glickson JD
    Biochim Biophys Acta; 1989 Dec; 1006(3):287-90. PubMed ID: 2597673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.
    Wilding P; Senior MB; Inubushi T; Ludwick ML
    Clin Chem; 1988 Mar; 34(3):505-11. PubMed ID: 3349601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo bone marrow lipid characterization with line scan Carr-Purcell-Meiboom-Gill proton spectroscopic imaging.
    Mulkern RV; Meng J; Bowers JL; Oshio K; Zuo C; Li H; Kraft RA; Williamson DS; Jaramillo D
    Magn Reson Imaging; 1997; 15(7):823-37. PubMed ID: 9309613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of multiple T2 proton relaxation processes in human head and imaging on the basis of selective and assigned T2 values.
    Gersonde K; Felsberg L; Tolxdorff T; Ratzel D; Ströbel B
    Magn Reson Med; 1984 Dec; 1(4):463-77. PubMed ID: 6571570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
    Okunieff P; Zietman A; Kahn J; Singer S; Neuringer LJ; Levine RA; Evans FE
    N Engl J Med; 1990 Apr; 322(14):953-8. PubMed ID: 2314447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton nuclear magnetic resonance lineshape studies on human blood plasma lipids from newborn infants, healthy adults, and adults with tumors.
    Hiltunen Y; Ala-Korpela M; Jokisaari J; Eskelinen S; Kiviniitty K
    Magn Reson Med; 1992 Jul; 26(1):89-99. PubMed ID: 1625571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
    Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
    Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence of transverse relaxation time T2 of biologic tissues on the interpulse delay time in Carr-Purcell-Meiboom-Gill (CPMG) measurements.
    Shioya S; Kurita D; Haida M; Fukuzaki M; Tanigaki T; Kutsuzawa T; Ohta Y
    Tokai J Exp Clin Med; 1997 May; 22(2):27-31. PubMed ID: 9608628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?
    Lim HM; Price TB; Marsh JC; Rainey PM; Gore JC; Armitage IM
    Yale J Biol Med; 1991; 64(1):63-77. PubMed ID: 1897263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the value of identifying the presence of malignant disease in human plasma by proton nuclear magnetic resonance spectroscopy.
    Buchthal SD; Hardy MA; Brown TR
    Am J Med; 1988 Oct; 85(4):528-32. PubMed ID: 3177400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
    Fossel ET; Carr JM; McDonagh J
    N Engl J Med; 1986 Nov; 315(22):1369-76. PubMed ID: 3022146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H NMR relaxation measurements of human tissues in situ by spatially resolved spectroscopy.
    Luyten PR; Anderson CM; den Hollander JA
    Magn Reson Med; 1987 May; 4(5):431-40. PubMed ID: 3600250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An NMR blood test for cancer: a critical assessment.
    Chmurny GN; Hilton BD; Halverson D; McGregor GN; Klose J; Issaq HJ; Muschik GM; Urba WJ; Mellini ML; Costello R
    NMR Biomed; 1988 Jun; 1(3):136-50. PubMed ID: 3079310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NMR blood test for cancer: current status.
    Fossel ET
    Cancer Cells; 1991 May; 3(5):173-82. PubMed ID: 1654067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsed NMR relaxometry of striated muscle fibers.
    English AE; Joy ML; Henkelman RM
    Magn Reson Med; 1991 Oct; 21(2):264-81. PubMed ID: 1745125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative analysis by online nuclear magnetic resonance using Carr-Purcell-Meiboom-Gill sequence with low refocusing flip angles.
    de Andrade FD; Netto AM; Colnago LA
    Talanta; 2011 Mar; 84(1):84-8. PubMed ID: 21315902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR properties of human median nerve at 3 T: proton density, T1, T2, and magnetization transfer.
    Gambarota G; Mekle R; Mlynárik V; Krueger G
    J Magn Reson Imaging; 2009 Apr; 29(4):982-6. PubMed ID: 19306447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid measurement of T1/T2: the DECPMG sequence.
    Mitchell J; Hürlimann MD; Fordham EJ
    J Magn Reson; 2009 Oct; 200(2):198-206. PubMed ID: 19625200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.